星空无限传媒

星空无限传媒
星空无限传媒 星空无限传媒
GettyImages-609179959-hero
headshot

Juliana Alvarez Argote, MD

Assistant Professor

view physician profile

Locations

  • Froedtert Hospital
  • Zablocki VA Medical Center

Specialties

  • Medical Oncology
  • Benign Hematology

Languages

  • Spanish

Education

  • MD - Doctor of Medicine

Biography

Dr. Juliana Alvarez-Argote received her medical degree from the Universidad del Valle, Cali, Colombia. She completed her Internal Medicine Residency from the University of Connecticut, Farmington, CT. Afterwards, she obtained her Transfusion Medicine and Blood banking fellowship at the University of Chicago, Chicago, IL, and then completed her fellowship in hematology and medical oncology at the 星空无限传媒, Milwaukee, WI. She is board certified in both internal medicine and transfusion medicine, and is board eligible in hematology and medical oncology.

Dr. Alvarez-Argote is currently an assistant professor in the division of hematology and medical oncology at the 星空无限传媒 and the Clement J. Zablocki VA Medical Center, both in Milwaukee, WI. Her professional interests include solid tumors, benign hematology, and gene therapy. She is currently part of a research project with Dr. Jeffrey Medin that focuses in gene therapy for sickle cell disease. She is a member of the Education Committee of the American Society of Gene and Cell Therapy.

Publications

  • (Benz S, Sherman KA, Dasanu CA, Alvarez-Argote J.) J Oncol Pharm Pract. 2024 Jun;30(4):697-704 PMID: 37350125 SCOPUS ID: 2-s2.0-85162616675 06/23/2023

  • (Wang X, McKillop WM, Dlugi TA, Faber ML, Alvarez-Argote J, Chambers CB, Wilber A, Medin JA.) J Gene Med. 2024 Jan;26(1):e3567 PMID: 37455676 SCOPUS ID: 2-s2.0-85165380220 07/17/2023

  • (Alvarez-Argote J, Dlugi TA, Sundararajan T, Kleynerman A, Faber ML, McKillop WM, Medin JA.) Transl Res. 2023 Apr;254:77-91 PMID: 36323381 SCOPUS ID: 2-s2.0-85145313487 11/03/2022

  • (Dasanu CA, Alvarez-Argote J, Goff CB.) Expert Opin Pharmacother. 2022 Aug;23(11):1239-1241 PMID: 35703589 SCOPUS ID: 2-s2.0-85131928853 06/16/2022

  • (Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J.) J Oncol Pharm Pract. 2020 Sep;26(6):1516-1519 PMID: 32028838 SCOPUS ID: 2-s2.0-85079465900 02/08/2020

  • (Alvarez-Argote J, Dasanu CA.) Expert Opin Biol Ther. 2019 Sep;19(9):927-935 PMID: 31272242 SCOPUS ID: 2-s2.0-85070812050 07/06/2019

  • (Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J.) J Oncol Pharm Pract. 2019 Apr;25(3):638-647 PMID: 30253729 SCOPUS ID: 2-s2.0-85059350839 09/27/2018

  • (Dasanu CA, Alvarez-Argote J, Limonadi FM, Codreanu I.) Expert Opin Biol Ther. 2019 Feb;19(2):99-104 PMID: 30556741 SCOPUS ID: 2-s2.0-85060297670 12/18/2018

  • (Alvarez Argote J, Dasanu CA.) Curr Med Res Opin. 2018 May;34(5):757-763 PMID: 28027687 SCOPUS ID: 2-s2.0-85045643814 12/29/2016

  • (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC.) J Oncol Pharm Pract. 2018 Apr;24(3):229-231 PMID: 28436313 04/25/2017

  • (Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA.) BBA Clin. 2016 Dec;6:12-8 PMID: 27331023 PMCID: PMC4900299 06/23/2016

  • (Choy B, Alvarez Argote J, Treml A.) Transfusion. 2016 Aug;56(8):1937 PMID: 27500918 SCOPUS ID: 2-s2.0-84982995109 08/09/2016

Publications of from the